Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Boehringer Ingelheim slashes price for HIV drug in developing countries
The company now issues short, non-assert declarations which can be given to all generic producers worldwide, prequalified by the WHO, and are free of license fees or other
The company now issues short, non-assert declarations which can be given to all generic producers worldwide, prequalified by the WHO, and are free of license fees or other
The Federal District Court of the District of Delaware has dismissed the Danish company’s claims against UK biotech Acambis, cancelling an upcoming trial over the allegations. Bavarian Nordic
Under the terms of the agreement, which will run for 18 months, Proteros will receive research funding fees and success payments for the generation and analyses of protein-ligand-structures
Southwest Oncology Group (SWOG) added that study participants would be given the choice of switching to Revlimid with dexamethasone. According to SWOG, the 198 patients enrolled in the
Pravachol, a cholesterol-lowering drug, has annual sales of over $861 million, according to Glenmark. The generics company said that it is manufacturing the formulation in its facility in
The combination pediatric vaccine, currently in phase III studies, shows potential to protect children in the first year of life against Neisseria meningitidis serogroups C (MenC) and Y
Vinita Gupta, president and managing director of Lupin, said: “We are delighted to receive final FDA approval for simvastatin tablets. The addition of generic Zocor complements Lupin’s commitment
Acambis developed ACAM2000 under contracts with the US Centers for Disease Control and Prevention in response to the US government’s need for a stockpile of smallpox vaccine to
New York-based Siga said that it expects the results from the study to be used as one of the two animal models required for the FDA’s “animal efficacy
The trial will test the hypothesis that patients with COPD are more likely to have a good clinical response to inhaled steroids if they have a positive Aridol